Breadcrumb Home investors intimation stock exchanges Intimation to stock Exchanges Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-20162014-20152013-20142012-20132011-20122010-2011 Apply Issuance of duplicate share certificates 28th Sep 2023 USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA 20th Sep 2023 Issuance of duplicate share certificates 15th Sep 2023 Issuance of duplicate share certificates 13th Sep 2023 Allotment of 7,188 equity shares under ESOS 2013-A Scheme and Cipla ESAR Scheme 2021 11th Sep 2023 Press Release - Cipla Medpro South Africa (Pty) Ltd, wholly owned subsidiary of the Company in South Africa to acquire Actor Pharma (Pty) Ltd., South Africa 04th Sep 2023 Investment in Actor Pharma (Pty) Ltd., South Africa 04th Sep 2023 Allotment of 47,205 equity shares under ESOS 2013-A Scheme and Cipla ESAR Scheme 2021 17th Aug 2023 Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 16th Aug 2023 Disclosure of material continuing events under Regulation 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) 14th Aug 2023 Pagination First page first Previous page ‹ Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 Next page › Last page last BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.
